Meanwhile, the result of the diabetes treatment with SGLT2is in the CANVAS, DECLARE-TIMI 58, and VERTIS-CV trials did not reach statistical significance in relation to cardiovascular death.
1
—
—
Meanwhile, the result of the diabetes treatment with SGLT2is in the CANVAS, DECLARE-TIMI 58, and VERTIS-CV trials did not reach statistical significance in relation to cardiovascular death.